Assembly Biosciences Inc. logo

Assembly Biosciences Inc.

ASMB | NASDAQ
Chart Builder DCF Calculator
$25.66
+$0.22 (+0.86%)
Sep 22, 2026, 12:48 PM ET · Market open

Market Data

Market Cap
$504.15M
Enterprise Value
$186.14M
Beta
1.13
Average Volume
223.22K
Shares Outstanding (Diluted)
18.85M
Shares Change YoY
146.26%
Institutional Ownership
80.29%
Exchange
NASDAQ
ISIN
US0453962070

Price Performance

Price Change 1M
-26.5%
Price Change 3M
-5.1%
Price Change 6M
-11.3%
Price Change YTD
-24.6%
Price Change 1Y
2.7%
Price Change 3Y
130.4%
Price Change 5Y
-37.1%
1M CAGR (ann.)
-4.7%
1Y CAGR (ann.)
14.2%
5Y CAGR (ann.)
-8.5%
All-Time CAGR
-15.7%

Valuation

PE Ratio
46.25
Forward PE
12.31
PEG Ratio
0.06
Forward PEG
0.12
PS Ratio
8.20
Forward PS
11.80
PB Ratio
1.65
P/FCF Ratio
-13.07
P/Adj. FCF Ratio
-11.15
P/OCF Ratio
-12.47
EV/Sales
3.03
EV/EBIT
48.79
EV/EBITDA
-76.32
EV/FCF
-4.83
Earnings Yield
2.2%
FCF Yield
-7.7%
Adj. FCF Yield
-9.0%

Financial Health

Net Cash
$318.01M
Total Debt
$2.35M
Cash & Short-Term Investments
$320.36M
Total Assets
$330.83M
Current Ratio
13.99
Quick Ratio
13.99
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.96
Debt / FCF
-0.06
OCF / Debt
-16.37
Interest Coverage
0.00
Altman Z-Score
9.76
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
77.7%
Operating Profit Margin
-14.3%
EBITDA Margin
0.1%
Net Profit Margin
-0.1%
FCF Margin
-62.7%
Adj. FCF Margin
-73.6%
SBC / Revenue
8.9%
SBC Impact (per share)
-17.3%

Returns

Return on Assets
0.0%
Return on Equity
0.0%
Return on Invested Capital
-2.9%
Return on Capital Employed
-2.9%
Return on Tangible Assets
0.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
51.6%
Revenue CAGR 5Y
11.5%
Revenue CAGR 10Y
12.9%
EPS CAGR 3Y
100.8%
EPS CAGR 5Y
57.0%
EPS CAGR 10Y
17.7%
FCF CAGR 3Y
-133.7%
FCF CAGR 5Y
24.0%
FCF CAGR 10Y
1.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
-220.6%
Revenue Growth Next 3Y
-23.7%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.66
EPS Growth Est (next Q)
-9.0%
Revenue Est (next Q)
$9.07M
Revenue Growth Est (next Q)
-15.9%

Fair Value Estimates

Graham Number
$14.16
Graham Upside
-44.3%
Lynch Fair Value
$13.75
Lynch Upside
-46.0%
Price Target
$51.67
Price Target Upside
103.1%

Cash Flow

Operating Cash Flow
$-38.48M
Free Cash Flow
$-38.57M
Adj. Free Cash Flow
$-45.23M
FCF Per Share
-$2.05
OCF Per Share
-$2.04
OCF/S Ratio
-51.4%

Income Statement

Revenue
$61.47M
Gross Profit
$44.83M
Operating Income
$-8.8M
EBITDA
$-2.44M
Net Income
$-42K
EPS (Diluted)
$0.55
Revenue / Employee
$842.07K
Profit / Employee
$-575.34
Employees
73

© 2026 bestshares.com. All rights reserved.